BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26511813)

  • 1. Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms.
    Kang J; Park JH; Lee HJ; Jo U; Park JK; Seo JH; Kim YH; Kim I; Park KH
    Cancer Res Treat; 2016 Apr; 48(2):715-26. PubMed ID: 26511813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.
    Zou M; Li Y; Xia S; Chu Q; Xiao X; Qiu H; Chen Y; Zheng Z; Liu F; Zhuang L; Yu S
    Cell Physiol Biochem; 2017; 44(2):778-791. PubMed ID: 29169152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage.
    Zheng Y; Dai Y; Liu W; Wang N; Cai Y; Wang S; Zhang F; Liu P; Chen Q; Wang Z
    J Cell Physiol; 2019 Apr; 234(4):4277-4290. PubMed ID: 30146689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Doddapaneni R; Patel K; Chowdhury N; Singh M
    Exp Cell Res; 2016 Aug; 346(1):65-73. PubMed ID: 27177833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
    Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
    Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
    Lim HK; Kim KM; Jeong SY; Choi EK; Jung J
    Integr Cancer Ther; 2017 Dec; 16(4):496-504. PubMed ID: 27151585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
    Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.
    Doddapaneni R; Patel K; Chowdhury N; Singh M
    Sci Rep; 2017 Nov; 7(1):15824. PubMed ID: 29158480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
    Khurana RK; Kumar R; Gaspar BL; Welsby G; Welsby P; Kesharwani P; Katare OP; Singh KK; Singh B
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():645-658. PubMed ID: 30033299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel.
    Feng LX; Li M; Liu YJ; Yang SM; Zhang N
    Int J Mol Sci; 2014 Mar; 15(3):4201-20. PubMed ID: 24619193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles with Optimal Ratiometric Co-Delivery of Docetaxel with Gambogic Acid for Treatment of Multidrug-Resistant Breast Cancer.
    Xu Y; Wang C; Ding Y; Wang Y; Liu K; Tian Y; Gao M; Li Z; Zhang J; Li L
    J Biomed Nanotechnol; 2016 Sep; 12(9):1774-81. PubMed ID: 29345888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor Efficacy of Docetaxel-loaded Nanocarrier against Esophageal Cancer Cell Bearing Mice Model.
    Huang ZJ; Yang N; Xu TW; Lin JQ
    Drug Res (Stuttg); 2015 Aug; 65(8):403-9. PubMed ID: 25188607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells.
    Caraglia M; Giuberti G; Marra M; Di Gennaro E; Facchini G; Caponigro F; Iaffaioli R; Budillon A; Abbruzzese A
    Front Biosci; 2005 Sep; 10():2566-75. PubMed ID: 15970518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumorigenic effects of a novel digitoxin derivative on both estrogen receptor-positive and triple-negative breast cancer cells.
    Kulkarni YM; Yakisich JS; Azad N; Venkatadri R; Kaushik V; O'Doherty G; Iyer AKV
    Tumour Biol; 2017 Jun; 39(6):1010428317705331. PubMed ID: 28618929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q
    Wang HM; Yang HL; Thiyagarajan V; Huang TH; Huang PJ; Chen SC; Liu JY; Hsu LS; Chang HW; Hseu YC
    Integr Cancer Ther; 2017 Sep; 16(3):385-396. PubMed ID: 27821721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
    Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
    J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
    Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
    Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.
    Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T
    Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.